RAD21 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.786600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.786000E-01
Normal-vs-Stage2
9.070600E-01
Normal-vs-Stage3
3.459200E-01
Normal-vs-Stage4
7.302400E-01
Stage1-vs-Stage2
8.972000E-01
Stage1-vs-Stage3
2.316200E-01
Stage1-vs-Stage4
6.532000E-01
Stage2-vs-Stage3
1.991820E-01
Stage2-vs-Stage4
6.483800E-01
Stage3-vs-Stage4
2.611200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.803200E-01
Normal-vs-AfricanAmerican
8.490400E-01
Normal-vs-Asian
9.950600E-01
Caucasian-vs-AfricanAmerican
6.384600E-01
Caucasian-vs-Asian
7.704600E-01
AfricanAmerican-vs-Asian
8.520400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.671400E-01
Normal-vs-Female
8.891600E-01
Male-vs-Female
8.042800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.197000E-01
Normal-vs-Age(41-60Yrs)
5.408600E-01
Normal-vs-Age(61-80Yrs)
9.752000E-01
Normal-vs-Age(81-100Yrs)
9.002200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.867410E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.008000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.943000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.437700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.708790E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.737200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.591800E-01
Normal-vs-Daily Drinker
8.641200E-01
Normal-vs-Weekly Drinker
4.640400E-01
Normal-vs-Occasional Drinker
4.054400E-01
Normal-vs-Social Drinker
8.407600E-01
Non Drinker-vs-Daily Drinker
9.616400E-01
Non Drinker-vs-Weekly Drinker
3.728200E-01
Non Drinker-vs-Occasional Drinker
3.747800E-02
Non Drinker-vs-Social Drinker
4.618800E-01
Daily Drinker-vs-Weekly Drinker
4.698800E-01
Daily Drinker-vs-Occasional Drinker
3.926200E-02
Daily Drinker-vs-Social Drinker
5.029600E-01
Weekly Drinker-vs-Occasional Drinker
1.002380E-02
Weekly Drinker-vs-Social Drinker
1.479840E-01
Occasional Drinker-vs-Social Drinker
1.667980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.565400E-01
Normal-vs-Grade 2
7.534200E-01
Normal-vs-Grade 3
2.406400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.867600E-01
Grade 1-vs-Grade 3
6.175000E-01
Grade 1-vs-Grade 4
5.565400E-01
Grade 2-vs-Grade 3
1.501790E-01
Grade 2-vs-Grade 4
7.534200E-01
Grade 3-vs-Grade 4
2.406400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.478000E-01
Normal-vs-NonDiabetic
9.194400E-01
Diabetic-vs-NonDiabetic
6.118600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.585800E-01
Normal-vs-NoPancreatitis
8.815800E-01
Pancreatitis-vs-NoPancreatitis
8.689600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.379200E-01
Normal-vs-N1
8.975200E-01
N0-vs-N1
6.969400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.827200E-01
Normal-vs-TP53-NonMutant
9.202000E-01
TP53-Mutant-vs-TP53-NonMutant
6.739600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
